Skip to content

For laboratory research use only — not for human or veterinary use

ReferenceGrowth-hormone secretagogue research

Sermorelin

GRF 1-29 · GHRH(1-29) · sermorelin acetate

The 1-29 fragment of GHRH, a classic reference growth-hormone-releasing peptide.

In development Get notified on release Browse in-stock catalog

About Sermorelin

Sermorelin is the biologically active 1-29 fragment of growth-hormone-releasing hormone and one of the longest-established reference GHRH peptides in research. It is studied as the parent sequence behind modified analogs such as CJC-1295. TagPep is adding sermorelin as a research-use-only reference material.

Mechanism studied in research

Agonism at the GHRH receptor using the shortest fully active fragment (residues 1–29) of native GHRH — the reference point for GHRH-analog research.

Areas of research investigation

  • GHRH-receptor research
  • GH-axis model systems
  • Structure-activity mapping of GHRH
  • Comparative analog studies

Laboratory handling

Lyophilized; reconstituted with bacteriostatic or sterile water for research and refrigerated; powder frozen and light-protected.

Sermorelin research FAQ

How does sermorelin relate to CJC-1295?

CJC-1295 is a modified, longer-acting version built on the sermorelin (GRF 1-29) sequence. Sermorelin is the shorter, native reference fragment.

Is sermorelin available now?

It is on TagPep's research roadmap. Contact us to be notified when a documented research-use-only batch is released.

Research use only. Sermorelin is supplied as a laboratory reference material for in-vitro and research applications. It is not a drug, supplement or medical product, and is not intended for human or veterinary use, consumption, or clinical application.